Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I should have brought more on Friday,...gradual ascent from here
Nice post!
I 2nd Rinoo on this, sorry Q
Good rebuttal Jess, the real question is do we buy more now or after Q3, you know we’ll hit the mid 20’s before the pop in January.
Good find Rinoo!
Ahhhhhh yes!
You’re forgiven, this link is real.
https://www.investorsobserver.com/news/stock-update/is-sorrento-therapeutics-inc-srne-stock-a-smart-investment-3
Meant Brother Jess, my bad
Rather Jess, I’m with ya , no doubt ....also, Wainwright just raised AUPH to 34 PT
I agree Rinoo, not to mention, so many inexperienced investors got into this stock as it jumped, not knowing anything about the company at all.Im long on SRNE, but if it were a TV show, the channel would be Bravo and my wife would be tuning in.
Rinoo brings it again, thanks dude !
We hit 15and nothing from you guys?
Thanks guys!!
What are the possibilities he was sharing information with China?
JD, excellent comment, hilarious and maybe even true, the CFO that got ousted is still on their website Under leadership ......take a look
You gotta clean the slate before the big event, he was probably skimming?
Good point Zep, the books have to be clean and the debt has to be low.WE BELIEVE in AUPH and a handful of biotech analysts believe in AUPH, but to attract the big money managers who can make this stock go up 50% with just their blessing, you have to have the secret sauce AND the balance sheet..
Good point Zep, the books have to be clean and the debt has to be low.WE BELIEVE in AUPH and a handful of biotech analysts believe in AUPH, but to attract the big money managers who can make this stock go up 50% with just their blessing, you have to have the secret sauce AND the balance sheet..
Bam, the Rinoo is en fuego today, we’ll done!
Right on Jess!
Hold out Slim, AUPH isn’t a profitable company currently and the business world is a brutal environment given the current situation.Companies with rock solid balance sheets are furloughing and firing employees, gold is at an all time high.Cash is king right now and the only solution for uncertainty. So, all we have is cash and the ability to combat LN and DES.
Q3 will bring another mediocre quarter....after that, hold on to your seat, the waiting will pay off.
Slim, I couldn’t agree more....I think we'll really start to see really aggressive behavior after Q3.
Great article Qsach, these are the reasons longs hold onto SRNE, you have to know and believe in the stocks you own.
He’ll address it Bdawg
It’s about time swung some lead!!
People selling on Russian news and Moderna, but forgetting SRNE’s saliva test, all of these vaccines are still a gamble, we”ll need testing
Aurinia notifications blowing up my inbox, of course revs we’re down, but things are finally coming together, January can’t come soon enough for us.
Amen Qsach, hell no!, plus zero long term data from their “vaccine”.
Jess, welcome to the party pal!
I couldn’t agree more with FITZ on Cramer....he does not highly endorse SPECS, especially the small caps
.I own NVAX and Moderna and Remember Cramer recommending viewers to sell off half of Moderna when it hit 32 and doing the same with Novavax. I’m a huge fan of Jim Cramer, and nobody knows stocks more than him, but he”s a long time investor, not a trader.
18, and we’re just getting warmed up.
Wait til next week Bdawg
Nobody’s buying biotechs today, tomorrow it’s on!,
Aurinia Pharmaceuticals (NASDAQ:AUPH) (TSE:AUP) was upgraded by ValuEngine from a "hold" rating to a "buy" rating in a research report issued on Monday, ValuEngine reports.
Passed 14, nothing but north from here.
Don’t look now, but we’re green...
Exactly, if it wasn’t for covid, we’d be sitting at 30 right now, everyone’s throwing their money into the flavor of the day right now, like Kodak.
I like Wainwright’s buy rating for AUPH and $33 Price target.
I have to post this for Slim and anyone else interested, the SUVRF company just raised 2million dollars at 4.50 a share, MORE THAN the current price of $2.77 a share, now this is how you raise funds, seems like a no brainer investment to me.Again because I like most of the people on this board.